MPS Pharmaa has announced its financial results for the quarter ended June 30. The company reported revenue from operations of ₹1.35 Cr, an increase from ₹1.26 Cr in the same quarter last year.

Net loss for the period improved significantly to ₹0.06 Cr, compared to a net loss of ₹0.13 Cr in the prior year's corresponding quarter.

This indicates an improving operational trajectory, successfully narrowing losses in a competitive pharmaceutical landscape.

The quarterly results have undergone a limited review by statutory auditors.